Methylene Blue MMX (R) increases adenoma detection rate in screening and surveillance colonoscopy- A multi-centre, multinational, placebo controlled, randomised, double-blind at randomisation, parallel-group, phase III study
Main Authors: | Repici, A, Wallace, M, East, J, Sharma, P, Bisschops, R, Ramirez, F, Bruining, D, Young, M, Gatof, D, Canto, M, Marcon, N, Cannizzaro, R, Kiesslich, R, Rutter, M, Dekker, E, Siersema, P, Spaander, M, Kupcinskas, L, Radaelli, F, Bhandari, P, Vieth, M, Hassan, C |
---|---|
Other Authors: | Elsevier |
Format: | Conference item |
Published: |
2018
|
Similar Items
-
Efficacy of per-oral methylene blue formulation for screening colonoscopy
by: Repici, A, et al.
Published: (2019) -
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.
by: Travis, S, et al.
Published: (2014) -
Once-Daily MMX Mesalamine in the Management of Ulcerative colitis
by: Wojciech Blonski, et al.
Published: (2011-01-01) -
The complete guide to MMX technology /
by: Intel Corporation
Published: (1997) -
Efficacy and tolerability of high- vs low-volume split-dose bowel cleansing regimens for colonoscopy: a systematic review and meta-analysis
by: Spadaccini, M, et al.
Published: (2019)